trending Market Intelligence /marketintelligence/en/news-insights/trending/ixiygwetbxvbkidggqx_ug2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Acceleron Pharma appoints chief medical officer

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Blog

COVID-19 Impact & Recovery: Private Equity

COVID-19 Impact & Recovery: Corporates

Blog

COVID-19 Impact & Recovery: Investment Banking


Acceleron Pharma appoints chief medical officer

Acceleron Pharma Inc. said July 5 that Robert Zeldin was appointed chief medical officer.

The Cambridge, Mass.-based biopharmaceutical company said Zeldin recently served as chief medical officer of Belgium-based Ablynx NV, now a unit of Sanofi.

Previously, Zeldin served as vice president and U.S. medical franchise head of respiratory and dermatology at Novartis AG's Novartis Pharmaceuticals and senior vice president and head of global clinical development at Stallergenes SA.